Page 12 - Optimal Management of Urologic Oncology During COVID-19

TRIAGING UROLOGIC ONCOLOGY SURGERY

BLADDER CANCER SURGERY

• LOW RISK T1, CIS – Radical Cystectomy can be delayed 3

months

• HIGH RISK, including neoadjuvant chemotherapy –

Radical Cystectomy should not be delayed beyond 1-2

months

• LOW GRADE Bladder Tumors – TURBT can be delayed 3-6

months

• HIGH GRADE Bladder Tumors – TURBT should not be

delayed beyond 1-2 months